A study of 20 antidepressants and over 30,000 patients found three medications may beat fluoxetine for long-term depression treatment results overall.
A study of 20 antidepressants and over 30,000 patients found three medications may beat fluoxetine for long-term depression treatment results overall.
Hilary Tesluck shares how kratom capsules led to a spiraling addiction, with her daily intake climbing to 100 capsules before she sought help.
The REDUCE trial found spironolactone lowered blood pressure by nearly eight points in stroke survivors, but key questions about prevention remain.
A Nature Health study finds potassium salt substitutes could prevent nearly 3 million deaths yearly, but hyperkalemia poses risks for some patients.
A Northwestern Medicine study found that marijuana users had objectively worse sleep quality, even though they didn't perceive their sleep as worse. Other experts weighed in.
PAHO has reportedly revoked the U.S. measles elimination status held since 2000, with over 5,412 confirmed cases in 2026 signaling continuous spread.
The American Cancer Society's new guidelines now recommend PSA blood tests every two years for men 50-69, with Black men urged to start annual screening at 45.
Sunharbo (asundexian) is the first FDA-approved factor XIa inhibitor for secondary stroke prevention, but key limitations and risks do remain.
A teen's severe allergic reaction to an energy drink was traced to cod collagen, revealing how fish-derived ingredients can hide in unexpected products.
A Stanford study found Type 2 diabetes patients on metformin had a 39% lower risk of dying in the year after a COVID-19 infection than others.